Dengue: all 284 studies
Page 2 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCompletedNCT00875524Phase 2Results posted
- Efficacy and Safety of Dengue Vaccine in Healthy ChildrenCompletedNCT00842530Phase 2Results posted
- Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsCompletedNCT00788151Phase 2Results posted
- Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USCompletedNCT00617344Phase 2Results posted
- A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenCompletedNCT00468858Phase 2Results posted
- A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve ChildrenCompletedNCT00384670Phase 1/2Results posted
- A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandCompletedNCT00370682Phase 2Results posted
- Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00350337Phase 2Results posted
- A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive InfantsCompletedNCT00322049Phase 1/2Results posted
- Safety and Immunogenicity Study of a Dengue Virus DNA VaccineCompletedNCT00290147Phase 1Results posted
- A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00239577Phase 2Results posted
- Efficacy and Safety of Indoor Residual Spray for Dengue Vector ControlCompletedNCT07838701Not applicable
- Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga® (TAK-003) Vaccine in Private Vaccination Centers, Including a Sub-analysis of Safety in Adults Over 60 Years of AgeActive, not recruitingNCT07812142
- Bridging Economics and Public Trust: A Study of Dengue Vaccine Cost-effectiveness and Acceptance in Thais Visiting HospitalActive, not recruitingNCT07759596
- Abdominal Sonographic Findings and Their Association With Thrombocytopenia in Dengue Fever: A Cross-Sectional Study From an Endemic RegionCompletedNCT07621848
- Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian CommunitiesCompletedNCT07517731Not applicable
- Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in VietnamActive, not recruitingNCT07501793
- Prediction of Infectious Diseases in LMICs Using Electronic Health Record DataCompletedNCT07432061
- A Controlled Human Infection Model of DengueActive, not recruitingNCT07412483Not applicable
- Evaluating Public Awareness and Preventive Actions for Dengue Fever in Sudan Amidst Ongoing CrisesCompletedNCT07205848
- Evaluation of T-cell Responses After Vaccination With the Attenuated Tetravalent Dengue Vaccine (Takeda).Active, not recruitingNCT07158190
- A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsActive, not recruitingNCT07047521Phase 3
- The Effectiveness of the Board Game on Primary Healthcare Nurses' Knowledge, Attitudes, and Confidence in Dengue-related PracticeCompletedNCT07028411Not applicable
- Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue PatientsCompletedNCT06945679Phase 1/2
- Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.CompletedNCT06898775
- Characteristics of Clinical Laboratory Indicators in Patients with Dengue FeverCompletedNCT06877039
- A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) InfectionCompletedNCT06799741Phase 2
- The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue FeverCompletedNCT06744777Phase 3
- A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in JapanCompletedNCT06741683Phase 2/3
- Clinical and Laboratory Factors for the Progression of Severe Dengue Among Hospitalized Patients During an UpsurgeCompletedNCT06697041
- The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return TravelersActive, not recruitingNCT06651372
- Citizen Action for Sustainable Dengue Control in Sub-Saharan AfricaCompletedNCT06648603Not applicable
- Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue PatientsActive, not recruitingNCT06642493Not applicable
- Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human MobilityActive, not recruitingNCT06599970
- Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At ScaleTerminatedNCT06595745Not applicable
- A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)Active, not recruitingNCT06579755Phase 3
- Study to Examine the Effects of Oral FenretinideCompletedNCT06528457Phase 2
- A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in MalaysiaActive, not recruitingNCT06388785
- Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal CoatingCompletedNCT06268691Not applicable
- Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West AfricaCompletedNCT06257810Not applicable
- Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical TrialCompletedNCT06121934Phase 3
- Homologous Re-infection With Dengue 1 or Dengue 3CompletedNCT05967455Phase 1
- Identification of Risk Determinants of Dengue Transmission Through Landscape AnalysisCompletedNCT05893134
- Effectiveness Evaluation of a Dengue Self-monitoring SystemCompletedNCT05688748Not applicable
- Effectiveness of a Online Education Material to Improve Dengue Knowledge and Health-Seeking IntentionStatus unknownNCT05661877Not applicable
- Anakinra in Dengue With Hyperinflammation ( AnaDen )Active, not recruitingNCT05611710Phase 2
- Evaluation Study of Dengue RDTsCompletedNCT05580731
- Impact of Project Wolbachia - Singapore on Dengue IncidenceCompletedNCT05505682Not applicable
- Spatial Repellents for Aedes-borne Virus Control in Sri LankaCompletedNCT05452447Not applicable
- Lymphocyte Count and High Fluorescent Count (HFLC) Correlate With Liver Disorder in Dengue Fever PatientsStatus unknownNCT05407181
- Study of AT-752 in Healthy Subjects in a Dengue Human Challenge ModelTerminatedNCT05366439Phase 1
- Educational Intervention to Promote Control Behaviors and Prevention of DengueCompletedNCT05321264Not applicable
- Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary CareCompletedNCT05307484Not applicable
- Dengue Controlled Human Infection Model in Dhaka, BangladeshActive, not recruitingNCT05229354Phase 2
- Baromètre Santé Adulte 2021-2022SuspendedNCT05218304Not applicable
- Dengue Vaccine Hesitancy and Acceptance in Endemic Regions of Argentina: Impact of Communication StrategiesStatus unknownNCT05213364
- Validation of a CDSA Strategy to Reduce Antibiotic Prescription in SenegalCompletedNCT05050825Not applicable
- Effectiveness Of High Dose Melatonin As Adjunctive Therapy For Dengue Fever With Warning SignsStatus unknownNCT05034809Phase 2
- Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French GuianaCompletedNCT04989673
- Serological Study of Dengue and Characterization of Immune Response in Ten Endemic and Non-Endemic Cities in MexicoStatus unknownNCT04947111Not applicable
- A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue VirusCompletedNCT04935801Phase 1
- Study on the Risks of Symptomatic Dengue on PregnancyStatus unknownNCT04826081
- Prospective Study on the Risks of Dengue Fever for the Fetus.Status unknownNCT04822441
- Study of AT-752 in Healthy SubjectsCompletedNCT04722627Phase 1
- Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue PatientsCompletedNCT04673422Phase 2/3
- Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina FasoCompletedNCT04582474Not applicable
- A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)CompletedNCT04514107Not applicable
- A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult ParticipantsWithdrawnNCT04480736Phase 2
- Characterizing Humoral Immune Response to Mosquito BitesCompletedNCT04478370Not applicable
- New Tools for Predicting Capillary Leak Shock During Dengue FeverStatus unknownNCT04422782Not applicable
- Metformin in Dengue With ObesityCompletedNCT04377451Phase 1/2
- Dengue 3 Human Infection Model (DENV-3)CompletedNCT04298138Phase 1
- Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRCStatus unknownNCT04235361
- Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in TaiwanCompletedNCT04133987Phase 2
- Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in ColombiaActive, not recruitingNCT04113330
- Resuscitation With Albumin 5% in Dengue Haemorrhagic FeverStatus unknownNCT04076254Phase 3
- Clinical Trial of Diagnostic Tests and Clinical Algorithms for Dengue in Febrile Subjects in Endemic Areas in ColombiaCompletedNCT04063774Not applicable
- Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in SingaporeCompletedNCT04048837
- A Phase 1 Safety Study of Dengusiil in Healthy AdultsCompletedNCT04035278Phase 1
- Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During PregnancyCompletedNCT04023708
- Assessing the Effectiveness of Sanofi Pasteur's Dengue Vaccine (Dengvaxia) Against Hospitalization and Symptomatic Infection in the State of Parana - BrazilCompletedNCT03960385
- Safety Study of Dengushield in Healthy AdultsCompletedNCT03883620Phase 1
- IC14 in Adult Patients With Dengue FeverWithdrawnNCT03875560Phase 2
- Expansion of a Dengue-1 Live Virus Human ChallengeCompletedNCT03869060Phase 1
- A Study of INO-A002 in Healthy Dengue Virus-naive AdultsCompletedNCT03831503Phase 1
- Dengue Effectiveness Study in the PhilippinesCompletedNCT03803618
- Combating Dengue With Innovative, Paradigm-shift-Strategies: Early Dengue Surveillance in Adult Aedes MosquitoesStatus unknownNCT03799237Not applicable
- Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue FeverCompletedNCT03632486
- Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, ColombiaCompletedNCT03631719
- Detection of Dengue Virus in Plasma of Patients in NepalCompletedNCT03620487
- Pilot Study to Detect DENGUE Virus in SpermCompletedNCT03612609Not applicable
- Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in ChildrenCompletedNCT03534245
- A Clinical Study to Evaluate TV003 in Healthy Adults in TaiwanCompletedNCT03485144Phase 2
- Dengue Serostatus Study in the PhilippinesActive, not recruitingNCT03465254
- Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue PatientsCompletedNCT03432442Phase 2
- Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 ChallengeCompletedNCT03416036Phase 1
- Neurologic Manifestations of the Arbovirus Infection in ColombiaCompletedNCT03206541
- Comparison of Tetravalent Dengue Virus Purified Inactivated Vaccine and Tetravalent Dengue Virus Live Attenuated VaccineStatus unknownNCT03141138Phase 1
- TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B AdjuvantWithdrawnNCT03110952Phase 1
- Applying Wolbachia to Eliminate DengueTerminatedNCT03055585Not applicable